Dental Practice EBITDA Valuation Multiples: What Buyers and Sellers Need to Know
General dentistry practices typically sell at 3.5x–6.5x EBITDA. Payer mix, active patient count, and key-person dependency are the variables that move the needle most.
Dental practices are valued primarily on a multiple of EBITDA, with collections-based rules of thumb (60–80% of trailing twelve-month collections) still used as a secondary check. Independent practice buyers using SBA financing typically pay 3.5x–5.0x EBITDA, while DSOs and PE-backed groups pursuing fee-for-service or multi-provider practices regularly push 5.5x–6.5x. EBITDA margins in the 15–30% range on $500K–$3M collections represent the sweet spot for acquirer interest. Key-person risk, payer mix quality, and hygiene recall strength are the primary valuation levers in every transaction.
Dental Practice EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or High-Risk Practice | $75K–$150K | 3.5x–4.0x | Heavy Medicaid exposure, sole-producer model, aging equipment, or declining active patient count. Limited buyer pool; SBA financing difficult to secure. |
| Average Independent Practice | $150K–$300K | 4.0x–5.0x | PPO-heavy payer mix, 800–1,200 active patients, single-provider with some staff stability. Typical SBA-financed transaction with seller carry of 10–20%. |
| Strong Fee-for-Service or Multi-Provider Practice | $300K–$500K | 5.0x–6.0x | Fee-for-service or strong PPO mix, 1,200+ active patients, associate producer reducing key-person risk. Attractive to both individual buyers and regional DSOs. |
| Premium DSO Target | $500K+ | 6.0x–6.5x | Multi-operatory, multi-provider practice with documented systems, strong hygiene recall, and minimal Medicaid. PE-backed DSOs compete aggressively for these assets. |
What Drives Dental Practice Multiples
Payer Mix Quality
High impactFee-for-service and PPO-dominant practices command 1.0x–1.5x higher multiples than Medicaid-heavy peers due to superior reimbursement rates and lower patient acquisition costs.
Active Patient Base and Recall Compliance
High impactPractices with 1,000+ active patients seen within 18 months and hygiene recall rates above 70% signal predictable recurring revenue and protect against post-close attrition.
Key-Person Dependency
High impactA selling dentist generating 90%+ of collections is a significant valuation discount trigger. An existing associate producing 20–30% of revenue can add 0.5x–1.0x to the multiple.
Equipment Condition and CapEx Needs
Medium impactPractices with digital X-ray, modern chairs, and no deferred maintenance avoid buyer-imposed price reductions of $50K–$150K common in older, underinvested offices.
Lease Terms and Location Stability
Medium impactA favorable lease with 5+ years remaining and landlord consent to assignment removes a key deal risk. Short or expiring leases can delay closings or reduce lender confidence.
Recent Market Trends
DSO consolidation has created a two-tier market in 2023–2024: premium fee-for-service practices are seeing record multiples above 6x as institutional buyers compete aggressively, while Medicaid-heavy or single-provider practices struggle to exceed 4x. Hygienist and assistant workforce shortages are compressing margins in high-cost metros, making labor stability a growing underwriting concern. SBA 7(a) remains the dominant financing vehicle for individual buyers, with lenders requiring minimum 15% EBITDA margins and clean three-year financials before approval.
Sample Dental Practice Transactions
Solo general dentist, suburban market, 950 active patients, PPO-heavy, seller staying 12 months post-close, SBA-financed asset purchase
$210,000
EBITDA
4.6x
Multiple
$966,000
Price
Two-provider practice, fee-for-service focus, 1,400 active patients, strong hygiene recall, associate in place reducing key-person risk
$380,000
EBITDA
5.7x
Multiple
$2,166,000
Price
Multi-operatory DSO tuck-in, 1,800 active patients, 85% PPO and 15% fee-for-service, equity rollover structure with earnout tied to production
$520,000
EBITDA
6.3x
Multiple
$3,276,000
Price
EBITDA Valuation Estimator
Get your Dental Practice business value range instantly
Industry: Dental Practice · Multiples based on 4.0x–5.0x (Average Independent Practice)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect for a general dentistry practice in 2024?
Most general dentistry practices sell between 3.5x and 6.5x EBITDA. Fee-for-service and multi-provider practices attract higher multiples from DSOs, while Medicaid-heavy solo practices land at the lower end.
Do DSOs pay higher multiples than individual buyers for dental practices?
Yes. DSOs and PE-backed groups typically pay 5.5x–6.5x EBITDA for premium practices, while individual buyers using SBA financing generally range from 4.0x–5.5x depending on practice quality and seller financing terms.
How does key-person risk affect my dental practice valuation?
If you generate 90%+ of collections personally, expect buyers to discount the multiple by 0.5x–1.0x or require a longer transition period. Adding an associate producer before selling is the most effective way to reduce this risk.
Can I sell my dental practice with SBA financing as the buyer's funding source?
Yes. SBA 7(a) loans are commonly used for dental practice acquisitions up to $5M. Lenders require 3 years of clean financials, minimum 15% EBITDA margins, and typically a 10% borrower down payment plus possible seller carry.
More Dental Practice Guides
Find Dental Practice businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required